# HA35 Moderate Alcoholic Hepatitis (AH) Study

> **NCT05018481** · EARLY_PHASE1 · RECRUITING · sponsor: **The Cleveland Clinic** · enrollment: 54 (estimated)

## Conditions studied

- Alcoholic Hepatitis

## Interventions

- **DRUG:** Sodium Hyaluronate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05018481
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-01
- **Primary completion:** 2026-10-01
- **Final completion:** 2027-10-01
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2025-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05018481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05018481, "HA35 Moderate Alcoholic Hepatitis (AH) Study". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT05018481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*